Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of Denosumab for Prevention of Bone Complications After Allogenic Hematopoietic Stem Cell Transplantation in Children

NCT02677246 is registered in ClinicalTrials.gov with St. Justine's Hospital as lead sponsor.

NCT NCT02677246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02677246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of Denosumab for Prevention of Bone Complications After Allogenic Hematopoietic Stem Cell Transplantation in Children
Lead sponsor
St. Justine's Hospital
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 2016
Completion date
September 4, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to bone marrow transplantation